BLAZE MEDICAL DEVICES

Blaze develops technologies that enable integrated and standardized assessments of blood damage, particularly for red blood cells (RBC). The company’s principal product lines include RBC Mechanical Fragilimeter™ systems for testing the mechanical fragility (MF) of red blood cells, and RBC Hemolysis Tester systems which also include the Fragilimeter™ capability. Initial models of these systems are for a wide range of industrial R&D and other research applications, while subsequent lines will target medical applications.